Comparison

(±)5-HEPE European Partner

Item no. HY-N7801
Manufacturer MedChem Express
CASRN 83952-40-3
Amount 1 ea
Specific against other
Citations [1]Powell, et al. Formation of a 5-oxo metabolite of 5,8,11,14,17-eicosapentaenoic acid and its effects on human neutrophils and eosinophils. J. Lipid Res. 36, 2590-2598 (1995).
Smiles CC/C=C\C/C=C\C/C=C\C/C=C\C=C\C(O)CCCC(O)=O
Available
Product Description
(±)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE. The biological activity of (±)5-HEPE is likely mediated by one of the individual isomers, most commonly the 5(S) isomer in mammalian systems. EPA can be metabolized to 5-HEPE in human and bovine neutrophils, and human eosinophils, which is further metabolized to 5-oxoEPE and LTB5. The 5-series metabolites of EPA, namely 5-HEPE, 5-oxoEPE, and LTB5, have significantly decreased biological effects compared to the arachidonic acid-derived metabolites.
Shipping
Room temperature
Manufacturers Applications
Metabolism-protein/nucleotide metabolism
MolecularWeight
318.45
Clinical Information
No Development Reported
Manufacturers Research Area
Metabolic Disease
Target
Others
Manufacturers Target
Others
Manufacturers Pathway
Others
Manufacturers Product type
Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close